AFT Pharmaceuticals Limited logo

SPH Notice – Bell Potter Securities Limited

Substantial Holder Notice21 September 2020AFTHealthcare

1
Disclosure of ceasing to have substantial holding

Section 279, Financial Markets Conduct Act 2013

To NZX Limited

and

To ASX Limited

and

To AFT Pharmaceuticals Limited ("AFT")

Date this disclosure made: 22 September 2020

Date last disclosure made: 15 June 2020

Date on which substantial holding ceased: 15 September 2020

Substantial product holder(s) giving disclosure

Full name(s): Bell Potter Securities Limited ("Bell Potter")

Summary of previous substantial holding

Class of quoted voting products: Ordinary shares in AFT

Summary for Bell Potter

For last disclosure,—

(a) total number held in class: 72,031,609

(b) total in class: 103,167,716

(c) total percentage held in class: 69.820%

For current holding after ceasing to have substantial holding,—

(a) total number held in class: 0

(b) total in class: 104,578,875

(c) total percentage held in class: 0%

Details of transactions and events giving rise to ceasing of substantial holding

Details of the transactions or other events requiring disclosure:

As recorded in the SPH notice disclosed by Bell Potter on 10 June 2020, on that date, Bell

Potter entered into a Placement and Sell Down Agreement with AFT, Forsyth Barr Group

Limited and others, under which Bell Potter and Forsyth Barr Group Limited agreed to

underwrite the placement and sell down, as further described in and attached to the SPH

notice disclosed by Bell Potter on 10 June 2020 ("Agreement").

Pursuant to the Agreement, Hartley Atkinson and Colin McKay undertook in favour of Bell

Potter, Forsyth Barr Limited and Forsyth Barr Group Limited certain restrictions in relation

to ordinary shares in AFT held by them (the "Shares"), including not to deal in the Shares

for a period of 3 months, beginning on 15 June 2020 and expiring on 15 September 2020.


2

Those restrictions have now lapsed and as a result Bell Potter no longer has a relevant

interest in those shares.

Additional information

Address(es) of substantial product holder(s): Bell Potter Securities Limited, Level 29, 101

Collins Street, Melbourne, Australia

Contact details:

Name: James Unger

Email: junger@bellpotter.com.au

Certification

I, James Unger, certify that, to the best of my knowledge and belief, the information

contained in this disclosure is correct and that I am duly authorised to make this disclosure

by all persons for whom it is made.

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.